NCT00002417View on ClinicalTrials.gov

A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications

NACompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Amprenavir

Trial Locations (1)

27709

Glaxo Wellcome Inc, Research Triangle Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Glaxo Wellcome

INDUSTRY

NCT00002417 - A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications | Biotech Hunter | Biotech Hunter